Skip to main content
. 2022 Dec 19;26(1):12–26. doi: 10.1038/s41593-022-01221-3

Fig. 7. Ferroptosis pharmacological inhibitors revealed in small-molecule screen.

Fig. 7

a, Schema and results for pharmacological compound screen in which 546 compounds were tested for their ability to block ferroptosis in an immortalized microglia cell line. Illustrations were created with BioRender. b, Thirty-nine of the 546 compounds rescued cell viability to at least 70% of the vehicle control (blue dots), and five rescued to at least 100%. Three technical replicates per compound. Red line indicates average cell survival with ferroptosis induction and no compound. c, Heat map of percent cell survival for the 39 hits and the Selleck-associated pathway or function. d, Heat map of percent cell survival for compounds predicted to interact with GPCR signaling, PI3K signaling or necroptosis by ChEMBL. e, Correlation between the targets of pharmacological hits and genes identified in the CRISPR screen that are associated with the targets, separated by general pathway/function. Illustrations were created with BioRender.